Trial Details
AuthorisedBasic Information
| Clinical ID | c3307 |
|---|---|
| Identifier | EUCTR2008-005015-17-NL |
| Trial Title | Effect of N-acetylcysteine on thiopurine related hepatotoxicity in IBD patients - NACTOX |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | adult patients (18-70 years old) who have been treated with azathioprine, 6-mercaptopure or 6-thioguanine for inflammatory bowel disease, in whom hepatotoxicity occured as an adverse event, are eligible. Prior to definite inclusion, the patients will be screened to make other causes of hepatotoxicity less likely. |
| Interventions | Trade Name: acetylcysteine Product Name: acetylcysteine Pharmaceutical Form: Effervescent tablet INN or Proposed INN: ACETYLCYSTEINE CAS Number: 616911 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 2400- |
Participant Information
| Sponsor | VU university medical centre |
|---|---|
| City | - |
| Country/Region | Netherlands |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | Not Available |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |